A

ABL Bio Inc
KOSDAQ:298380

Watchlist Manager
ABL Bio Inc
KOSDAQ:298380
Watchlist
Price: 27 150 KRW 2.84% Market Closed
Market Cap: 1.3T KRW
Have any thoughts about
ABL Bio Inc?
Write Note

ABL Bio Inc
Change in Working Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ABL Bio Inc
Change in Working Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
A
ABL Bio Inc
KOSDAQ:298380
Change in Working Capital
-â‚©41.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Change in Working Capital
-â‚©165.1B
CAGR 3-Years
11%
CAGR 5-Years
-61%
CAGR 10-Years
-14%
SK Bioscience Co Ltd
KRX:302440
Change in Working Capital
-â‚©35.7B
CAGR 3-Years
N/A
CAGR 5-Years
-14%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Change in Working Capital
-â‚©50.4B
CAGR 3-Years
-56%
CAGR 5-Years
-43%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Change in Working Capital
-â‚©4.2B
CAGR 3-Years
-24%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Change in Working Capital
â‚©18.4B
CAGR 3-Years
155%
CAGR 5-Years
84%
CAGR 10-Years
N/A
No Stocks Found

ABL Bio Inc
Glance View

Market Cap
1.3T KRW
Industry
Biotechnology

ABL Bio, Inc. engages in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2018-12-19. The major products include anti-angiogenesis antibodies anti-tumor targeting antibodies, T cell engager bispecific antibodies (TCEs), dual immune cell targeting bispecific antibodies (DICs), novel immune cell targeting antibodies (NICs), brain disease dual antibodies, antibody-drug conjugates (ADCs) , among others.

Intrinsic Value
8 401.38 KRW
Overvaluation 69%
Intrinsic Value
Price
A

See Also

What is ABL Bio Inc's Change in Working Capital?
Change in Working Capital
-41.5B KRW

Based on the financial report for Jun 30, 2024, ABL Bio Inc's Change in Working Capital amounts to -41.5B KRW.

Back to Top